GenomeMe Lab Inc. is a Vancouver-based biotech company specializing in mouse and rabbit IHC (immunohistochemistry) monoclonal antibodies for clinical diagnostic use. Since our inception in 2017, our goal has been to develop each of the 260+ clinical IHC antibodies in-house, making us the first and only institution to date to achieve this. We are on track to reach this R&D goal by the end of 2021 - hitting a monumental milestone in the history of our company’s development. Because we develop and manufacture all of our antibodies in-house, we are able to offer our distributors, OEM partners, and valuable end user customers the best value and quality. GenomeMe Lab Inc. is rising to be a dominant player in diagnostic IHC applications, an increasingly essential part of future precision medicine technologies.
View Top Employees from GenomeMeWebsite | http://www.genomeme.ca |
Revenue | $1 million |
Employees | 7 (7 on RocketReach) |
Founded | 2017 |
Address | 1-3691 Viking Way, Richmond, British Columbia V6V 2J6, CA |
Phone | (604) 244-9962 |
Technologies | |
Industry | Hospitals and Health Care, Biotechnology, Personalized Medicine, Pharmaceuticals, Genetic Analysis, Healthcare, Infectious Disease Diagnostics, Molecular Pathology |
Web Rank | 3 Million |
Keywords | Genomeme, Ihc116 Genomeme, Genomeme P16 |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 325413 Companies, NAICS Code 3254 Companies |
Looking for a particular GenomeMe employee's phone or email?
The GenomeMe annual revenue was $1 million in 2024.
Mark Fox is the CEO of GenomeMe.
7 people are employed at GenomeMe.
GenomeMe is based in Richmond, British Columbia.
The NAICS codes for GenomeMe are [32, 32541, 325, 325413, 3254].
The SIC codes for GenomeMe are [28, 283].